Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
2
50%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

terminated125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_4

Treatment of Vascular Stiffness in ADPKD

NCT05228574
completednot_applicable

Test the Phototoxicity of Sunscreen Products

NCT02802930
completednot_applicable

To Test for Photo Allergy Reaction of Sunscreens

NCT02872220
terminatedphase_3

STRIDE - STimulating Immune Response In aDvanced brEast Cancer

NCT00925548

Clinical Trials (4)

Showing 4 of 4 trials
NCT05228574Phase 4

Treatment of Vascular Stiffness in ADPKD

Completed
NCT02802930Not Applicable

Test the Phototoxicity of Sunscreen Products

Completed
NCT02872220Not Applicable

To Test for Photo Allergy Reaction of Sunscreens

Completed
NCT00925548Phase 3

STRIDE - STimulating Immune Response In aDvanced brEast Cancer

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4